Effects of Adding Oxycodone to Ropivacaine on Labor Analgesia: A Randomized Controlled Trial.

Effects of Adding Oxycodone to Ropivacaine on Labor Analgesia: A Randomized Controlled Trial.

Zhong, H Y;Yang, Z Y;Zhang, W;Cai, S;
the clinical journal of pain 2019
189
zhong2019effectsthe

Abstract

It has been reported that oxycodone is superior to the other opioids for the treatment of visceral pain. During the first stage of labor, pain is mainly caused by uterine contractions (visceral pain). It appears that oxycodone is more suitable for labor analgesia. During this study, we investigated the effects of adding oxycodone to ropivacaine on epidural analgesia during labor.Eighty nulliparous parturients were randomly divided into two groups. Group A received 0.2▒mg/mL oxycodone plus 0.1% ropivacaine for epidural analgesia and Group C (control group) received 0.1% ropivacaine alone for epidural analgesia. The onset time and duration of analgesia, duration of labor stages, delivery outcome, analgesic effect, Bromage scores, blood pressure, heart rate and neonatal Apgar scores were recorded. Umbilical arterial blood was collected to analyze. Side effects, if any, were also recorded.The visual analogue scale (VAS) of pain was lower at 2 h and 4 h after analgesia, and 10▒cm cervical dilatation in group A compared to group C (P=0.021, P=0.018, and P=0.009, respectively). The onset time of analgesia was shorter in group A than that in group C (13.3±2.8 vs. 14.9±3.6▒min, P=0.032). There were no significant differences between the two groups in terms of the duration of labor stages, delivery outcome, Bromage score, neonatal Apgar score and umbilical arterial blood pH. The duration of analgesia was significantly longer in group A than in group C (326.2±56.5 vs. 68.4±10.5▒min, P=0.000), but the incidence of pruritus was higher in group A than in group C (10% vs. 0%, P=0.115).This study demonstrates that epidural oxycodone may accelerate the onset of analgesia and obviously prolong the duration of analgesia during labor without increasing adverse effects associated with the neonate. However, it may cause a higher incidence of maternal pruritus. (Registration number: ChiCTR1800016483).

Citation

ID: 68382
Ref Key: zhong2019effectsthe
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
68382
Unique Identifier:
10.1097/AJP.0000000000000777
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet